As shown in Figure 4C, we found that JMJD6 is upregulated in different cancers, with melanoma being one of the cancer having higher levels of JMJD6 expression and high genomic alteration frequency (with amplification in almost 3% of cases, Supplementary Figure S4A). Here, JMJD6 is linked to cancer.